In our analysis, the ROC curve showed that IFIT1/2/3/5 had a high ability to distinguish AML from normal blood tissues (AUC > 0.9), suggesting that IFIT family members are promising diagnostic biomarkers for AML. This evidence concerns the gene IFIT1 and acute myeloid leukemia.